Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

NCT03282123 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

PTSD

Interventions

DRUG: Midomafetamine
BEHAVIORAL: Manualized therapy

Sponsor

Resilient Pharmaceuticals